Skip to main content
OpenTrials
Completed

NCT Number: NCT00549991

Analyzing Genes That May Increase the Risk of Developing High Blood Pressure

High blood pressure is one of the most common health problems in the United States. Genetic variations may cause some people to be more susceptible to developing high blood pressure. This study will identify variations in genes known to play a part in the development of high blood pressure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Case Western Reserve University

Cleveland, Ohio, 44106, United States

About this study

High blood pressure affects nearly one third of all individuals in the United States. It is especially common in African Americans, with more than 40% of African Americans diagnosed with this condition. High blood pressure usually develops earlier in life and is more severe in African Americans than in other racial or ethnic groups. Many factors can cause high blood pressure, including stress, diet, diabetes, kidney disease, or obesity. Previous studies have also shown that genetic variations on two regions of chromosomes 6 and 21 may predispose some people to develop high blood pressure. Admixture mapping is a type of genetic analysis that aims to identify disease-causing genetic variations across different populations of people. Using admixture mapping, this study will examine previously collected genetic samples from African American participants in the Family Blood Pressure Program (FBPP) study and from African American, Mexican American, Nigerian, and Jamaican participants enrolled in other clinical studies. Study researchers will analyze the samples to identify and characterize genetic variations that are associated with an increased risk of high blood pressure in the African American population, as well as other racial and ethnic groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participated in the FBPP study (African American [800 people with high blood pressure and 800 control group participants] and Mexican American participants)
  • Participated in the American Family Study (African American participants)
  • Participated in the Phenotyping Study (African American, Nigerian, and Jamaican participants)

Treatment and study plan

Primary outcomes

  1. Genetic variations

    Time frame: Measured through admixture mapping genetic analysis

Sponsors and collaborators

Lead sponsor

Case Western Reserve University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Official study title

Fine Mapping of Hypertension Genes Detected by Admixture Mapping in the FBPP

Important dates

Study start
2007
Primary completion
2012
Study completion
2012
First posted
Oct 26, 2007
Registry last updated
Sep 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.